Ambarella To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Wednesday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their price targets and ratings for several companies, including United Therapeutics, BILL Holdings, Ambarella, Albemarle, Cognizant Technology Solutions, Nordstrom, The Toro Company, Twilio, Ulta Beauty, and Delek Logistics Partners. These changes reflect varying outlooks on the companies' future performance.
August 28, 2024 | 1:16 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
B of A Securities raised Nordstrom's price target from $18 to $20, maintaining an Underperform rating. The stock fell 2.5% to $21.14.
Despite the raised price target, the Underperform rating and stock decline suggest negative sentiment and potential downside risk.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 85
NEGATIVE IMPACT
Deutsche Bank cut Ulta Beauty's price target from $552 to $448, maintaining a Buy rating. The stock fell 1% to $371.35.
The significant cut in the price target suggests concerns, but the Buy rating indicates long-term confidence. Short-term downside risk is likely.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 90
NEUTRAL IMPACT
Evercore ISI Group cut Albemarle's price target from $190 to $170, maintaining an Outperform rating. The stock rose 0.04% to $88.98.
The reduced price target may indicate some concerns, but the maintained Outperform rating suggests continued confidence in the company's prospects.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 85
NEUTRAL IMPACT
Mizuho lowered the price target for BILL Holdings from $60 to $52, maintaining a Neutral rating. The stock rose 7.5% to $53.48.
Despite the lowered price target, the stock's rise suggests positive market sentiment or other factors influencing the price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 85
NEUTRAL IMPACT
RBC Capital raised Cognizant's price target from $81 to $82, maintaining a Sector Perform rating. The stock rose 0.4% to $77.15.
A slight increase in the price target with a Sector Perform rating suggests a stable outlook with limited short-term impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
NEUTRAL IMPACT
Baird increased The Toro Company's price target from $100 to $102, maintaining a Neutral rating. The stock gained 0.2% to $90.60.
A minor increase in the price target with a Neutral rating suggests a stable outlook with limited short-term impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Craig-Hallum raised Ambarella's price target from $80 to $85, maintaining a Buy rating. The stock gained 3.2% to close at $52.79.
The increase in price target and Buy rating from Craig-Hallum indicates a positive outlook, likely to boost investor confidence and stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 90
POSITIVE IMPACT
Citigroup raised Delek Logistics Partners' price target from $44 to $45 and upgraded the stock from Neutral to Buy. The stock fell 0.4% to $38.83.
The upgrade to Buy and increased price target suggest a positive outlook, likely to improve investor sentiment despite the recent decline.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 85
POSITIVE IMPACT
Bernstein boosted Twilio's price target from $68 to $70, maintaining a Market Perform rating. The stock gained 2.2% to $61.99.
The increased price target and stock gain suggest a positive outlook, likely boosting investor sentiment.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 85
POSITIVE IMPACT
Oppenheimer raised the price target for United Therapeutics from $400 to $575, maintaining an Outperform rating. The stock closed at $349.23, up 0.7%.
The significant increase in the price target by Oppenheimer suggests strong confidence in United Therapeutics' future performance, likely boosting investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90